Professional
Added to YB: 2025-10-20
Pitch date: 2025-10-10
MEDP [neutral]
Medpace Holdings, Inc.
-2.3%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$507.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Headwaters Capital Portfolio Holding: Medpace Holdings, Inc.
MEDP (holding update): +64% return driven by strong bookings despite tough biotech funding environment. Aggressive share repurchases (10% of shares bought back over last year) during weakness. Cyclical end markets but disciplined capital allocation & steady market share gains make it core long-term holding.
Read full article (1 min)